期刊文献+

LC-MS/MS方法测定人血浆中艾普拉唑及其代谢产物艾普拉唑砜的浓度 被引量:3

Development and validation of a selective and robust LC-MS/MS method for quantifying ilaprazole and its metabolite ilaprazole sulfone in human plasma
暂未订购
导出
摘要 A liquid chromatography-tandem mass spectrometric method (LC-MS/MS) for quantifying ilaprazole and its major metabolite in human plasma was developed and validated. Sample preparation was based on chloroform extraction. Chromatography was performed on a C18 analytical column and the retention times were 1.2, 1.28 and 1.65 min for ilaprazole, ilaprazole sulfone and omeprazole (internal standard), respectively. The ionization was optimized using ESI (+) and enhanced selectivity achieved by tandem mass spectrometric analysis. The calibration curve ranged from 0.36 to 368.40 ng/mL and from 0.125 to 128.000 ng/mL for ilaprazole and ilaprazole sulfone, respectively. The intra-and inter-day precision (CV) were within 15%, and accuracy of ilaprazole and ilaprazole sulfone were within 80% to 120%. The analytes showed stable over the timescale of the whole procedure. The robustness of the method was demonstrated by good reproducibility of results obtained from the analysis of clinical samples. A liquid chromatography-tandem mass spectrometric method (LC-MS/MS) for quantifying ilaprazole and its major metabolite in human plasma was developed and validated. Sample preparation was based on chloroform extraction. Chromatography was performed on a C18 analytical column and the retention times were 1.2, 1.28 and 1.65 min for ilaprazole, ilaprazole sulfone and omeprazole (internal standard), respectively. The ionization was optimized using ESI (+) and enhanced selectivity achieved by tandem mass spectrometric analysis. The calibration curve ranged from 0.36 to 368.40 ng/mL and from 0. 125 to 128.000 ng/mL for ilaprazole and ilaprazole sulfone, respectively. The intra- and inter-day precision (CV) were within 15%, and accuracy of ilaprazole and ilaprazole sulfone were within 80% to 120%. The analytes showed stable over the timescale of the whole procedure. The robustness of the method was demonstrated by good reproducibility of results obtained from the analysis of clinical samples.
出处 《中国临床药理学与治疗学》 CAS CSCD 2007年第10期1190-1190,共1页 Chinese Journal of Clinical Pharmacology and Therapeutics
关键词 LC-MS/MS 人血浆 艾普拉唑 代谢产物 艾普拉唑砜 浓度测定 mass spectrometry ilaprazole ilaprazole sulfone
  • 相关文献

同被引文献27

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部